What is the evidence for Mangiferin in skincare?

Best-evidenced use: grade D for Topical antioxidant / brightening / anti-aging appearance (human). Mangiferin is a xanthonoid polyphenol from mango with a strong in-vitro antioxidant and anti-inflammatory profile, which is why it appears in some antioxidant cosmetic formulations. As with several plant polyphenols in this register, the honest picture for skin is thin: there is little controlled human topical evidence, and poor solubility and a yellow tint are the practical limits. Skin penetration, long assumed to be the barrier, has been measured on human skin ex vivo: mangiferin crosses the stratum corneum and reaches the epidermis and dermis. That removes the usual explanation for the missing results without supplying any. Much of the broader mangiferin literature concerns ingestible use, which is outside this topical register's scope. A genuinely potent antioxidant molecule with little cosmetic clinical evidence behind the skincare framing.

What does the evidence for Mangiferin not show?

Topical antioxidant / brightening / anti-aging appearance (human): Potent antioxidant in a dish, minimal evidence on real skin — the familiar gap. ECM-enzyme inhibition — elastase & collagenase (mechanism): An enzyme-assay result is a reason to run a trial, not the result of one. No human outcome supports it, which is why it sits at D rather than with the mechanism grade above. Pigmentation effects (mechanism): Not a demonstrated pigment outcome on skin.

What can Mangiferin honestly claim?

Honest claim: antioxidant support for the look of protected skin. Claims beyond the register's allowed list are out of scope.

Mangiferin — the mango xanthonoid antioxidant: strong in-vitro, thin topical data

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Mangiferin changes - nothing else.

Identity

Mangiferin is a xanthonoid — a polyphenol built on a xanthone core — found most famously in mango (Mangifera indica), and also in other plants. In cosmetics it is used under the INCI name Mangiferin as a plant antioxidant. (It is also marketed as an ingestible supplement for metabolic and other effects — that use is outside this register's topical scope.)

Mechanism (as proposed)

Mangiferin is a potent free-radical scavenger in the lab, with well-described antioxidant and anti-inflammatory activity, and some in-vitro reports of effects on melanin pathways. The laboratory pharmacology is genuinely strong — the recurring trap for plant polyphenols. Two practical limits temper it on skin: mangiferin is poorly water-soluble and carries a yellow tint that complicates formulation. Skin penetration, the usual third limit cited for polyphenols, has been measured here and is not one: two ex vivo studies on human skin found mangiferin crosses the stratum corneum into the epidermis and dermis, and the 2017 work also reported reversible, non-competitive inhibition of elastase and collagenase. Delivery is therefore not what stands between the in-vitro result and living tissue; controlled human trials are.

Reading the evidence honestly

The decisive gap is the missing study type: there is little controlled human topical data on mangiferin for any skin outcome. The cosmetic case rests on in-vitro antioxidant and anti-inflammatory results, and "potent antioxidant in a dish" has a poor record of translating to visible human benefit — hence the D grade despite a strong laboratory profile. Where mangiferin has a larger evidence base, it concerns ingestible metabolic and anti-inflammatory effects, which this topical register does not cover.